These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3814762)

  • 1. Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives.
    Olivesi A
    Biomed Pharmacother; 1986; 40(8):301-8. PubMed ID: 3814762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased metabolic clearance of acetaminophen with oral contraceptive use.
    Abernethy DR; Divoll M; Ochs HR; Ameer B; Greenblatt DJ
    Obstet Gynecol; 1982 Sep; 60(3):338-41. PubMed ID: 6897933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol.
    Seidegård J; Simonsson M; Edsbäcker S
    Clin Pharmacol Ther; 2000 Apr; 67(4):373-81. PubMed ID: 10801246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
    Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
    Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How rapid is the return of fertility after the use of Tri-Regol oral contraceptive?
    Adám J
    Ther Hung; 1992; 40(1):16-9. PubMed ID: 1585278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline pharmacokinetics in adolescent females following coadministration of oral contraceptives.
    Koren G; Chin TF; Correia J; Tesoro A; MacLeod SM
    Clin Invest Med; 1985; 8(3):222-6. PubMed ID: 4042465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early effect of a low dose (30 micrograms) ethinyl estradiol-containing Triphasil on vitamin B6 status. A follow-up study on six menstrual cycles.
    Massé PG; van den Berg H; Duguay C; Beaulieu G; Simard JM
    Int J Vitam Nutr Res; 1996; 66(1):46-54. PubMed ID: 8698546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
    Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA; Bonnar J
    Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term effects of low-dose combined norethisterone and combined 18-metayl-norethisterone on lipid metabolism in healthy women].
    Li Y; Dong G; Wu Y
    Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):680-3. PubMed ID: 11218899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations with Anteovin with special regard to its cycle-regulating action.
    Hetényi G
    Ther Hung; 1987; 35(3):164-8. PubMed ID: 3438880
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in prednisolone disposition as a result of oral contraceptive use and dose.
    Meffin PJ; Wing LM; Sallustio BC; Brooks PM
    Br J Clin Pharmacol; 1984 Jun; 17(6):655-64. PubMed ID: 6743464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.